Home » Authors » Brady Huggett

Brady Huggett

Articles

ARTICLES

London AIM Market Gaining Weight, Challenging Nasdaq

July 3, 2006

By Brady Huggett

London AIM Market Gaining Weight, Challenging Nasdaq

July 3, 2006

By Brady Huggett

Pharma's Antibody Hunger Behind Technology Buyouts

June 19, 2006

By Brady Huggett

Pharma's Shopping Continues, With Focus On Antibody Firms

June 16, 2006

By Brady Huggett

Pharma's Shopping Continues, With Focus On Antibody Firms

June 16, 2006

By Brady Huggett

With IPO Investors Stingy, Trubion Seeking $86.25M

June 8, 2006

By Brady Huggett

With IPO Investors Stingy, Trubion Seeking $86.25M

June 8, 2006

By Brady Huggett

Biogen Buying Fumapharm, Consolidating BG-12 Rights

June 7, 2006

By Brady Huggett

Biogen Buying Fumapharm, Consolidating BG-12 Rights

June 7, 2006

By Brady Huggett

Biogen Buying Fumapharm, Consolidating BG-12 Rights

June 1, 2006

By Brady Huggett

View All Articles by Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.